Bioreactor Market by Type (Stirred Tank Bioreactor, Airlift Bioreactor, Packed Bed Bioreactor, Fluidized Bed Bioreactor, Photo Bioreactor, Others); by Application (Stem Cells, T Cells, Mammalian Cell, Others); by Regions (North America, Asia Pacific, Europe, the Middle East & Africa and Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2015-2021.


Report ID : RNR-197267 Category : Medical Devices Published Date : Nov - 2017
Publisher : Research-N-Reports Pages : 123 Format : PDF
Bioreactors are fabricated vessels or frameworks that help a biologically dynamic environment, as cells require a particular environment to develop. Typically, they vary in size from liters to cubic meters and are regularly made of stainless steel for the substantial scale generation of therapeutics. In the biopharmaceutical field, smaller glass bioreactors more often intended for R&D work and process advancement scale-up. In the meantime, single-use bioreactors, otherwise called disposable bioreactors, have been discovering extensive research and manufacturing use. Bioreactors can work as a batch, fed-batch, or consistently stirred-tank reactor frameworks.

The Global Bioreactor Market, in terms of revenue, which was esteemed at US$ 565.64 million in 2015, is relied upon to achieve an estimation of US$ 787.57 million by 2021, developing at a CAGR of 6.9% throughout the forecast time frame. The market is segmented on the basis of type into Stirred Tank Bioreactor, Airlift Bioreactor, Packed Bed Bioreactor, Fluidized Bed Bioreactor, Photo Bioreactor, and Others. Representing over XX% of the aggregate share of the market, the Airlift Bioreactor Segment will be the dominant segment of the market amid the forecast period as it holds the largest share of the market. From the application segments studied in the report, the Stem Cells Segment is projected to be dominant throughout the forecast period. 

Rising predominance of chronic diseases and growing biopharmaceutical investments will drive the Worldwide Bioreactor Market Size. Growing demand for therapeutically effective vaccines, product advancement, and favorable government activities to enhance medicinal services infrastructure will additionally stimulate business development. Customized pharmaceuticals are changing the way numerous diseases are distinguished, categorized, and treated. The developing personalized medicine market that includes a focused population base will additionally drive the bioreactor market size. Another manufacturing technologies have been developed to give more customized drug products, for example, 3D bioprinting. The expansion in the adoption of single-use innovations, use of hybrid technologies: single-use and stainless steel, developing ubiquity of single-use bioreactor among biopharmaceutical organizations, and developing biologics are impelling the development of the bioreactors market. In any case, administrative concerns identified with single-use bioreactors, issues in regards to leachable and extractable identified with single-use bags is hampering the development of this market. Besides, extensive scale disposable of plastic derivatives is a developing environmental concern limiting business development.

North America represented a significant share of the Global Bioreactor Market in 2016 and is relied upon to double the growth of the overall market in the coming years. Representing over XX% of the aggregate share of the global market, the regional Market is projected to be the largest market throughout the forecast period and is evaluated to reach $US 600 Million by 2024 owing to the increasing number of biopharmaceutical companies responsible for bringing new medicines to patients and their collaborations with venture capital firms, academic institutions, and patients. Germany Market subsidized to more than 25% of the regional income share inferable from the presence of prime industry players and rising medicinal expenditure in this region. Favorable administrative policies for biopharmaceutical endorsement and technological advancement in bioprocess equipment will impel business development. The Asia-Pacific Market is anticipated to grow at the highest CAGR during the forecast period. Growing population, increasing prevalence of chronic diseases, rising R&D investment, and unmet healthcare needs will stimulate industry growth. China, for instance, is the most preferred destination for leading biopharma companies for the production of biologics and has attracted significant investment in this field.

The report provides both, qualitative and quantitative research of the market, as well as encompasses worthy insights into the rational scenario and favored improvement methods adopted by key contenders. Some of the primary players of the Global Bioreactor Market are Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, BBI-Biotech, Biotron, Cellexus, Fermentec, Finesse, and Zenith among others.
TOC